Clinical trials using gene therapy to boost the body’s production of clotting factor aim to remove the need for regular infusions — ideally giving patients years or even decades free from daily worry about their condition.
Clinical trials using gene therapy to boost the body’s production of clotting factor aim to remove the need for regular infusions — ideally giving patients years or even decades free from daily worry about their condition.
Researchers from the Abigail Wexner Research Institute at Nationwide Children’s Hospital, visited the Columbus Metropolitan Library with the goal to improve health literacy in the Parsons community.
Highest jump was among 15- to 17-year-olds and more pronounced in girls; Dramatic increases in self-harm
and substance use as reasons for ED visits
How a urology and nephrology affinity group redefined the meaning of collaborative research, propelling field-changing innovations in translational medicine
Researchers broaden the understanding chromatin architecture in human disease.
Researchers characterize a component that stabilizes biofilms, a step toward learning ways to disrupt protection of harmful bacteria.
